Skip to main content
Contact Us
Subscribe
E-Edition
37°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
Tickers
ALLK
GILD
GRFS
IBB
Tags
SNDX
NVS
News
From
Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of GDP Report
December 22, 2021
Tickers
AIR
BB
CTAS
DRI
Tags
Eurozone
Markets
Earnings
From
Benzinga
Novartis Inks Option Agreement For BeiGene Anti-Cancer Therapy For Over $1B
December 20, 2021
Tickers
BGNE
NVS
Tags
NVS
Movers
News
From
Benzinga
Novartis' Ligelizumab Suffers Setback In Late-Stage Skin Disorder Studies
December 20, 2021
Tickers
NVS
Tags
why it's moving
News
Briefs
From
Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
Tickers
ACRDF
AFCG
ARNA
BBRRF
Tags
News
cannabis news California
FFLWF
From
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Tickers
ASRT
ATRS
BIIB
CALT
Tags
RHHBY
CALT
News
From
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
NVS
Movers
why it's moving
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 15, 2021
Tickers
ADGI
ALZN
BFRI
BGNE
Tags
IMAB
BGNE
YINN
From
InvestorPlace
Could This Soaring Biotech Stock Make You Rich?
December 15, 2021
Tickers
BLUE
KRYS
NVS
Tags
NVS
Market News
KRYS
From
Motley Fool
Molecular Partners Inks License Deal With Novartis For $580M
December 14, 2021
Tickers
MOLN
NVS
Tags
Movers
NVS
News
From
Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers
APTO
ATRA
AZN
BLU
Tags
MRNA
SGTX
Small Cap
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 14, 2021
Tickers
ALZN
APTO
ATRA
BOIL
Tags
SSL
ATRA
ALZN
From
InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
Tickers
ARNA
AVCNF
JAZZ
JNJ
Tags
NVS
TLRY
News
From
Benzinga
7 CEOs That Ought to Follow Jack Dorsey Out the Door
December 10, 2021
Tickers
ATVI
CAG
CCL
FIS
Tags
FIS
LW
WU
From
InvestorPlace
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
December 09, 2021
Tickers
NVS
REGN
Tags
REGN
General
Health Care
From
Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
December 08, 2021
Tickers
NVS
Tags
Benzinga
Market News
breast cancer
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Tickers
AAL
AAPL
ACEL
AMGN
Tags
C
AAL
AAPL
From
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
DTIL
ALNY
FMTX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
December 03, 2021
Tickers
ACEL
AFL
AGIO
ALHC
Tags
XOS
Upgrades
ACEL
From
Benzinga
Why Aurinia Pharmaceuticals Stock Bolted Higher Today
December 02, 2021
Tickers
AUPH
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
Market News
ALPMY
Trading Ideas
From
Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
Tickers
AI
AUPH
BMY
GSK
Tags
BMY
NASDAQ:AUPH,NYSE:NVS,NYSE:BMY,NYSE:GSK,NYSE:TWTR,NYSE:SQ,NYSE:AI
Today's Market
From
InvestorPlace
Breakthrough Cancer Therapy? This Biotech Shares Preclinical Data and Ambitious Plans
December 02, 2021
Tickers
AZN
NVS
PFE
Tags
PFE
Benzinga
Market News
From
Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Tickers
ACST
AMGN
BNTX
CMMB
Tags
General
DCTH
SPPI
From
Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Tickers
AMGN
AZN
BMY
HZNP
Tags
VRTX
Stocks to Buy
Market News
From
InvestorPlace
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
Tickers
MOLN
NVS
Tags
News
Briefs
Movers
From
Benzinga
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
Tickers
BMY
NVS
VTRS
Tags
Market News
NVS
VTRS
From
Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
Tickers
BNTX
JNJ
MRK
NVS
Tags
JNJ
OGN
M&A
From
Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
Tickers
ALNY
ARWR
DRNA
JNJ
Tags
NVS
ALNY
Recent Press Releases
From
Motley Fool
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
Tickers
AMGN
AZN
BIIB
BMY
Tags
RHHBY
NVS
SNY
From
Motley Fool
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.